TCR2 Therapeutics Inc. - Common Stock (NQ:TCRR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about TCR2 Therapeutics Inc. - Common Stock

< Previous 1 2 3 Next >

Esperion Therapeutics And 2 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

May 11, 2023

The Dow Jones closed slightly lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Recap: TCR2 Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

Ribbon Communications And 2 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

May 08, 2023

The Dow Jones jumped more than 500 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2023 ↗

March 24, 2023

Via Benzinga

What To Know About Jefferies's Downgrade of TCR2 Therapeutics ↗

March 09, 2023

Via Benzinga

4 Analysts Have This to Say About TCR2 Therapeutics ↗

March 09, 2023

Via Benzinga

Adaptimmune Agrees To Merge With Another Cell Therapy Focused Company ↗

March 06, 2023

Via Benzinga

Where TCR2 Therapeutics Stands With Analysts ↗

January 06, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023 ↗

March 09, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023 ↗

March 08, 2023

Via Benzinga

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason ↗

March 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 ↗

March 07, 2023

Via Benzinga

Why Is TCR2 Therapeutics Stock Trading Higher Today? ↗

March 06, 2023

TCR² Therapeutics (NASDAQ: TCRR) shares are trading higher on Monday after the company and Adaptimmune Therapeutics (NASDAQ: ADAP) announced an agreement under which the two companies will combine to...

Via Benzinga

Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 06, 2023

Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 06, 2023

Via Benzinga

Why Is TCR2 Therapeutics (TCRR) Stock Up 30% Today? ↗

March 06, 2023

A new deal offers a lifeline for TCRR stock and a compatible investment for Adaptimmune. Both companies are targeting solid cancer tumors.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 06, 2023

Via Benzinga

CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC ↗

January 06, 2023

Gene-editing stocks have not been immune when it comes to job losses and workforce reductions. Here are a few of the latest.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

December 16, 2022

During Friday's trading, 293 companies set new 52-week lows.

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 15, 2022

On Thursday, 241 companies hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 22, 2022

Thursday's session saw 329 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

December 14, 2022

On Wednesday, 115 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

December 12, 2022

Monday saw 196 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 09, 2022

On Friday, 127 companies set new 52-week lows.

Via Benzinga

Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday ↗

November 21, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 09, 2022

On Wednesday, 283 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.